[go: up one dir, main page]

PL2197287T5 - Zastosowanie szczepu bifidobacterium do wytwarzania kompozycji przeznaczonej do zapobiegania i/lub leczenia objawów typu alergicznego - Google Patents

Zastosowanie szczepu bifidobacterium do wytwarzania kompozycji przeznaczonej do zapobiegania i/lub leczenia objawów typu alergicznego

Info

Publication number
PL2197287T5
PL2197287T5 PL08858623.5T PL08858623T PL2197287T5 PL 2197287 T5 PL2197287 T5 PL 2197287T5 PL 08858623 T PL08858623 T PL 08858623T PL 2197287 T5 PL2197287 T5 PL 2197287T5
Authority
PL
Poland
Prior art keywords
preparing
preventing
composition
treating allergic
bifidobacterium strain
Prior art date
Application number
PL08858623.5T
Other languages
English (en)
Other versions
PL2197287T3 (pl
Inventor
Cécile AUBERT-JACQUIN
Francis Lecroix
Emmanuel Perrin
Valérie PETAY
Original Assignee
Compagnie Gervais Danone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39580478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2197287(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Compagnie Gervais Danone filed Critical Compagnie Gervais Danone
Publication of PL2197287T3 publication Critical patent/PL2197287T3/pl
Publication of PL2197287T5 publication Critical patent/PL2197287T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
    • A23C21/026—Whey; Whey preparations containing, or treated with, microorganisms or enzymes containing, or treated only with, lactic acid producing bacteria, bifidobacteria or propionic acid bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pediatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL08858623.5T 2007-10-03 2008-10-02 Zastosowanie szczepu bifidobacterium do wytwarzania kompozycji przeznaczonej do zapobiegania i/lub leczenia objawów typu alergicznego PL2197287T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0706925A FR2921795B1 (fr) 2007-10-03 2007-10-03 Utilisation d'une souche de bifidobacterium,pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique
EP08858623.5A EP2197287B2 (fr) 2007-10-03 2008-10-02 Utilisation d'une souche de bifidobacterium, pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique
PCT/FR2008/001372 WO2009074754A1 (fr) 2007-10-03 2008-10-02 Utilisation d'une souche de bifidobacterium, pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique

Publications (2)

Publication Number Publication Date
PL2197287T3 PL2197287T3 (pl) 2020-11-16
PL2197287T5 true PL2197287T5 (pl) 2025-05-05

Family

ID=39580478

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08858623.5T PL2197287T5 (pl) 2007-10-03 2008-10-02 Zastosowanie szczepu bifidobacterium do wytwarzania kompozycji przeznaczonej do zapobiegania i/lub leczenia objawów typu alergicznego

Country Status (11)

Country Link
US (1) US9707258B2 (pl)
EP (1) EP2197287B2 (pl)
CN (2) CN105724570A (pl)
AR (1) AR068726A1 (pl)
BR (1) BRPI0817905A2 (pl)
ES (1) ES2782375T5 (pl)
FR (1) FR2921795B1 (pl)
MY (1) MY168203A (pl)
PL (1) PL2197287T5 (pl)
RU (1) RU2522282C2 (pl)
WO (1) WO2009074754A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011121379A1 (en) * 2010-03-30 2011-10-06 Assistance Publique - Hopitaux De Paris Use of bifidobacteria for preventing allergy in breastfed infants
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
US20130287874A1 (en) * 2010-11-11 2013-10-31 Nestec S.A. Spoonable yogurt preparations containing non-replicating probiotic micro-organisms
EP3406267A1 (en) 2011-03-25 2018-11-28 Children's Medical Center Corporation Lin28-mediated control of let-7 biogenesis
WO2014168474A1 (en) 2013-04-08 2014-10-16 N.V. Nutricia Fermented nutritional composition with thiol protease inhibitor
RU2663065C2 (ru) 2013-11-04 2018-08-01 Н.В. Нютрисиа Ферментированное детское питание с неперевариваемыми олигосахаридами
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物
EP3544575A1 (en) 2016-11-23 2019-10-02 GOJO Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2019212329A1 (en) * 2018-04-30 2019-11-07 N.V. Nutricia Formula with specific beta-lactoglobulin peptides
JP7602478B2 (ja) * 2019-11-11 2024-12-18 株式会社ヤクルト本社 オリゴ糖を含む発酵乳の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
FR2795917B1 (fr) * 1999-07-06 2001-08-31 Gervais Danone Sa Procede de preparation d'un produit lacte immunostimulant et ses applications
NZ537242A (en) * 2002-06-21 2008-10-31 Newcastle Innovation Ltd Probiotic propionibacterium jensenii 702
KR100507417B1 (ko) * 2003-01-27 2005-08-10 (주) 피엘바이오 알레르기 질환 예방 및 치료 기능을 가진 유산균과 이를 함유한 항알레르기 제품
US20050175630A1 (en) * 2003-12-23 2005-08-11 Eyal Raz Immunogenic compositions and methods of use thereof

Also Published As

Publication number Publication date
MY168203A (en) 2018-10-15
ES2782375T3 (es) 2020-09-14
US9707258B2 (en) 2017-07-18
FR2921795B1 (fr) 2011-04-29
PL2197287T3 (pl) 2020-11-16
WO2009074754A1 (fr) 2009-06-18
RU2522282C2 (ru) 2014-07-10
EP2197287A1 (fr) 2010-06-23
RU2010117248A (ru) 2011-11-10
ES2782375T5 (en) 2025-06-02
EP2197287B2 (fr) 2025-03-12
AR068726A1 (es) 2009-12-02
US20100221226A1 (en) 2010-09-02
BRPI0817905A2 (pt) 2014-10-07
CN105724570A (zh) 2016-07-06
FR2921795A1 (fr) 2009-04-10
EP2197287B1 (fr) 2020-01-08
CN101848643A (zh) 2010-09-29

Similar Documents

Publication Publication Date Title
PL2197287T5 (pl) Zastosowanie szczepu bifidobacterium do wytwarzania kompozycji przeznaczonej do zapobiegania i/lub leczenia objawów typu alergicznego
IL232956A0 (en) Treatment and prevention of Edosis
ZA201107789B (en) Antimicrobial composition and related method of use
EP2271218A4 (en) USE AND COMPOSITION FOR THE TREATMENT OF DEMENTIA
SI2320911T1 (sl) Vazokonstrikcijski sestavki in metode uporabe
ZA200908711B (en) Methods and compositions for treating allergic diseases
PL2448581T3 (pl) Kompozycje terapeutyczne i odnośne sposoby ich stosowania
HRP20160902T1 (hr) Pripravci i postupci uporabe forbolskih estera
IL205977A0 (en) 5-anilinoimidazopyridines and methods of use
IL210997A0 (en) Compositions for the treatment of mrsa and uses thereof
EP2231665A4 (en) NEW COMPOSITIONS AND METHODS OF USE
IL206125A0 (en) Azaindolizines and methods of use
EP2282648A4 (en) PREBIOTIC COMPOSITIONS AND MANUFACTURING AND USE METHOD THEREFOR
EP2271750A4 (en) URICASE COMPOSITIONS AND METHODS OF USE
PL2170359T3 (pl) Zastosowanie otoczek drożdży do leczenia i/lub zapobiegania hiperinsulinemii
EP2416796A4 (en) Modified dnase compositions and methods of use thereof
ZA201004894B (en) Nuctraceutical composition and methods of use
ZA201004893B (en) Nuctraceutical composition and methods of use
EP2470016A4 (en) SYNERGISTIC COMPOSITION AND METHOD OF USE
GB2461611B (en) Composition and use thereof
GB0714500D0 (en) composition and treatment
GB0909792D0 (en) Composition and uses thereof
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
IL218428A0 (en) Multi-site modified sp1 ploypeptides and uses thereof
GB0820804D0 (en) Perinropril composition and method of use thereof